OM
NPSP

Opaleye Management’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Opaleye Management’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-150,000
Closed -$4.49M – 39
2014
Q1 		$4.49M Sell
150,000
-55,000
-27% -$1.9M 3.32% 9
2013
Q4 		$5.95M Buy
+205,000
New +$5.65M 4.67% 5

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Opaleye Management's NPSP Position: Q2 2014 in Review

Opaleye Management sold out of NPS PHARMACEUTICALS INC (NPSP) in Q2 2014, closing a stake of 150,000 shares — an estimated $4.49M sold.

Opaleye Management first reported a position in NPSP in Q4 2013 and held it in 2 quarters. The position peaked at $5.95M in Q4 2013. 215 funds tracked by Wall St. Rank hold NPSP as of Q2 2014.

  • Opaleye Management reported no remaining NPS PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Opaleye Management sold 150,000 NPS PHARMACEUTICALS INC shares in Q2 2014, an estimated $4.49M.
  • Opaleye Management first reported a position in NPS PHARMACEUTICALS INC in Q4 2013 and held it in 2 quarters.
  • Opaleye Management's NPS PHARMACEUTICALS INC position peaked at $5.95M in Q4 2013.
  • 215 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q2 2014.

Based on Opaleye Management's 13F filing for Q2 2014, filed 14 Aug 2014.